$99,047,470

Procurement of doxycycline hyclate tablets and amoxicillin trihydrate capsules for the Strategic National Stockpile under an ongoing contract that began in 2022.

Ensures domestic antibiotic supply for pandemic and biodefense preparedness; doxycycline is critical for plague and anthrax post-exposure prophylaxis.

Sustained demand signals continued reliance on pharmaceutical manufacturers for bulk antibiotic production; supply chain resilience for essential medicines.

U.S. antibiotic manufacturing capacity remains vulnerable; China supplies ~80% of active pharmaceutical ingredients globally, including doxycycline precursors.